163 related articles for article (PubMed ID: 34650695)
21. LncRNA MALAT1 promotes colorectal cancer development by sponging miR-363-3p to regulate EZH2 expression.
Xie JJ; Li WH; Li X; Ye W; Shao CF
J Biol Regul Homeost Agents; 2019; 33(2):331-343. PubMed ID: 30972996
[TBL] [Abstract][Full Text] [Related]
22. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway.
Guo X; Wang Y
Cancer Med; 2020 Jul; 9(14):5235-5246. PubMed ID: 32462698
[TBL] [Abstract][Full Text] [Related]
23. [Mechanism of long non-coding RNA-metastasis associated lung adenocarcinoma transcript 1 induced invasion and metastasis of esophageal cancer cell EC-109].
Zhang QQ; Cui YH; Wang Y; Kou WZ; Cao F; Cao XJ; Miao ZH; Kang XH
Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):405-411. PubMed ID: 28635228
[No Abstract] [Full Text] [Related]
24. LncRNA MALAT1 acts as a miR-125a-3p sponge to regulate FOXM1 expression and promote hepatocellular carcinoma progression.
Liu S; Qiu J; He G; Liang Y; Wang L; Liu C; Pan H
J Cancer; 2019; 10(26):6649-6659. PubMed ID: 31777593
[No Abstract] [Full Text] [Related]
25. Transcript-level regulation of MALAT1-mediated cell cycle and apoptosis genes using dual MEK/Aurora kinase inhibitor "BI-847325" on anaplastic thyroid carcinoma.
Samimi H; Haghpanah V; Irani S; Arefian E; Sohi AN; Fallah P; Soleimani M
Daru; 2019 Jun; 27(1):1-7. PubMed ID: 31077090
[TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA MALAT1 regulates oxaliplatin-resistance via miR-324-3p/ADAM17 axis in colorectal cancer cells.
Fan C; Yuan Q; Liu G; Zhang Y; Yan M; Sun Q; Zhu C
Cancer Cell Int; 2020; 20():473. PubMed ID: 33005106
[TBL] [Abstract][Full Text] [Related]
27. miR-140-3p inhibits breast cancer proliferation and migration by directly regulating the expression of tripartite motif 28.
Zhou Y; Wang B; Wang Y; Chen G; Lian Q; Wang H
Oncol Lett; 2019 Apr; 17(4):3835-3841. PubMed ID: 30881504
[TBL] [Abstract][Full Text] [Related]
28. MALAT1/ mir-1-3p mediated BRF2 expression promotes HCC progression via inhibiting the LKB1/AMPK signaling pathway.
Li GZ; Meng GX; Pan GQ; Zhang X; Yan LJ; Li RZ; Ding ZN; Tan SY; Wang DX; Tian BW; Yan YC; Dong ZR; Hong JG; Li T
Cancer Cell Int; 2023 Aug; 23(1):188. PubMed ID: 37653482
[TBL] [Abstract][Full Text] [Related]
29. The m6A methyltransferase METTL3 controls epithelial-mesenchymal transition, migration and invasion of breast cancer through the MALAT1/miR-26b/HMGA2 axis.
Zhao C; Ling X; Xia Y; Yan B; Guan Q
Cancer Cell Int; 2021 Aug; 21(1):441. PubMed ID: 34419065
[TBL] [Abstract][Full Text] [Related]
30. lncRNA MALAT1 modulates oxaliplatin resistance of gastric cancer via sponging miR-22-3p.
Zhang Z; Li M; Zhang Z
Onco Targets Ther; 2020; 13():1343-1354. PubMed ID: 32104001
[TBL] [Abstract][Full Text] [Related]
31. Long ncRNA MALAT1 promotes cell proliferation, migration, and invasion in prostate cancer via sponging miR-145.
Zhang D; Fang C; Li H; Lu C; Huang J; Pan J; Yang Z; Liang E; Liu Z; Zhou X; Xin Z; Chen Y; Cai Q
Transl Androl Urol; 2021 Jun; 10(6):2307-2319. PubMed ID: 34295718
[TBL] [Abstract][Full Text] [Related]
32. MALAT1 Knockdown Inhibits the Proliferation, Migration, and Collagen Deposition of Human Hypertrophic Scar Fibroblasts via Targeting miR-29a-3p/Smurf2 Axis.
Guo C; Liu X; Qiu K; Tu L; Liu D
Clin Cosmet Investig Dermatol; 2024; 17():1387-1404. PubMed ID: 38881700
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNA MALAT1 knockdown inhibits progression of anaplastic thyroid carcinoma by regulating miR-200a-3p/FOXA1.
Gou L; Zou H; Li B
Cancer Biol Ther; 2019; 20(11):1355-1365. PubMed ID: 31500506
[TBL] [Abstract][Full Text] [Related]
34. Long non-coding RNA MALAT1 regulates proliferation, apoptosis, migration and invasion via miR-374b-5p/SRSF7 axis in non-small cell lung cancer.
Song J; Su ZZ; Shen QM
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1853-1862. PubMed ID: 32141554
[TBL] [Abstract][Full Text] [Related]
35. Long Non-Coding MALAT1 Functions as a Competing Endogenous RNA to Regulate Vimentin Expression by Sponging miR-30a-5p in Hepatocellular Carcinoma.
Pan Y; Tong S; Cui R; Fan J; Liu C; Lin Y; Tang J; Xie H; Lin P; Zheng T; Yu X
Cell Physiol Biochem; 2018; 50(1):108-120. PubMed ID: 30278452
[TBL] [Abstract][Full Text] [Related]
36. LncRNA
Ye W; Ma J; Wang F; Wu T; He M; Li J; Pei R; Zhang L; Wang Y; Zhou J
Oxid Med Cell Longev; 2020; 2020():8184314. PubMed ID: 33274006
[TBL] [Abstract][Full Text] [Related]
37. LncRNA MALAT1 inhibits the proliferation and invasiveness of laryngeal squamous cell carcinoma Hep-2 cells by modulating miR-362-3p.
Xie B; Wang Z; Li T; Xue J; Zhang C
Am J Transl Res; 2022; 14(6):3729-3740. PubMed ID: 35836842
[TBL] [Abstract][Full Text] [Related]
38. The lncRNA MALAT1 functions as a competing endogenous RNA to regulate MCL-1 expression by sponging miR-363-3p in gallbladder cancer.
Wang SH; Zhang WJ; Wu XC; Weng MZ; Zhang MD; Cai Q; Zhou D; Wang JD; Quan ZW
J Cell Mol Med; 2016 Dec; 20(12):2299-2308. PubMed ID: 27420766
[TBL] [Abstract][Full Text] [Related]
39. lncRNA MALAT1 promotes diabetic retinopathy by upregulating PDE6G via miR-378a-3p.
Li X
Arch Physiol Biochem; 2024 Apr; 130(2):119-127. PubMed ID: 34674599
[TBL] [Abstract][Full Text] [Related]
40. Effect of Exosomal lncRNA MALAT1/miR-370-3p/STAT3 Positive Feedback Loop on PI3K/Akt Pathway Mediating Cisplatin Resistance in Cervical Cancer Cells.
Hu Y; Li G; Ma Y; Luo G; Wang Q; Zhang S
J Oncol; 2023; 2023():6341011. PubMed ID: 36793374
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
